High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study,: Proffered paper (oral presentation) 187O

Tessa Gerjanne Steenbruggen; Lars Steggink; C.M. Seynaeve; JJM van der Hoeven; Maartje J. Hooning; A Jager; IR Konings; J.R. Kroep; WM Smit; V. C. G. Tjan-Heijnen; E van der Wall; AD Bins; SC Linn; M Schaapveld; FE van Leeuwen; Carolina Schröder; H van Tinteren; E. G. E. de Vries; G. S. Sonke; Jourik A. Gietema

High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study, Proffered paper (oral presentation) 187O

Tessa Gerjanne Steenbruggen, Lars Steggink, C.M. Seynaeve, JJM van der Hoeven, Maartje J. Hooning, A Jager, IR Konings, J.R. Kroep, WM Smit, V. C. G. Tjan-Heijnen, E van der Wall, AD Bins, SC Linn, M Schaapveld, FE van Leeuwen, Carolina Schröder, H van Tinteren, E. G. E. de Vries, G. S. Sonke, Jourik A. Gietema

Onderzoeksoutput › Academic

Originele taal-2	English
Status	Published - 2018
Evenement	European Society for Medical Oncology 2018 meeting - Duur: 19-okt.-2018 → 23-okt.-2018

Conference

Conference	European Society for Medical Oncology 2018 meeting
Periode	19/10/2018 → 23/10/2018

Handle.net

Permanente koppeling

Citeer dit

Steenbruggen, T. G., Steggink, L., Seynaeve, C. M., van der Hoeven, JJM., Hooning, M. J., Jager, A., Konings, IR., Kroep, J. R., Smit, WM., Tjan-Heijnen, V. C. G., van der Wall, E., Bins, AD., Linn, SC., Schaapveld, M., van Leeuwen, FE., Schröder, C., van Tinteren, H., de Vries, E. G. E., Sonke, G. S., & Gietema, J. A. (2018). High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study, Proffered paper (oral presentation) 187O. Abstract van European Society for Medical Oncology 2018 meeting.

Steenbruggen, Tessa Gerjanne ; Steggink, Lars ; Seynaeve, C.M. et al. / High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study, Proffered paper (oral presentation) 187O. Abstract van European Society for Medical Oncology 2018 meeting.

@conference{4b330be2f4154708b8a11816bc4f13b6,

title = "High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study,: Proffered paper (oral presentation) 187O",

author = "Steenbruggen, {Tessa Gerjanne} and Lars Steggink and C.M. Seynaeve and {van der Hoeven}, JJM and Hooning, {Maartje J.} and A Jager and IR Konings and J.R. Kroep and WM Smit and Tjan-Heijnen, {V. C. G.} and {van der Wall}, E and AD Bins and SC Linn and M Schaapveld and {van Leeuwen}, FE and Carolina Schr{\"o}der and {van Tinteren}, H and {de Vries}, {E. G. E.} and Sonke, {G. S.} and Gietema, {Jourik A.}",

year = "2018",

language = "English",

note = "European Society for Medical Oncology 2018 meeting ; Conference date: 19-10-2018 Through 23-10-2018",

}

Steenbruggen, TG, Steggink, L, Seynaeve, CM, van der Hoeven, JJM, Hooning, MJ, Jager, A, Konings, IR, Kroep, JR, Smit, WM, Tjan-Heijnen, VCG, van der Wall, E, Bins, AD, Linn, SC, Schaapveld, M, van Leeuwen, FE, Schröder, C, van Tinteren, H, de Vries, EGE, Sonke, GS & Gietema, JA 2018, 'High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study, Proffered paper (oral presentation) 187O', European Society for Medical Oncology 2018 meeting, 19/10/2018 - 23/10/2018.

High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study, Proffered paper (oral presentation) 187O. / Steenbruggen, Tessa Gerjanne; Steggink, Lars; Seynaeve, C.M. et al.
2018. Abstract van European Society for Medical Oncology 2018 meeting.

Onderzoeksoutput › Academic

TY - CONF

T1 - High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study,

T2 - European Society for Medical Oncology 2018 meeting

AU - Steenbruggen, Tessa Gerjanne

AU - Steggink, Lars

AU - Seynaeve, C.M.

AU - van der Hoeven, JJM

AU - Hooning, Maartje J.

AU - Jager, A

AU - Konings, IR

AU - Kroep, J.R.

AU - Smit, WM

AU - Tjan-Heijnen, V. C. G.

AU - van der Wall, E

AU - Bins, AD

AU - Linn, SC

AU - Schaapveld, M

AU - van Leeuwen, FE

AU - Schröder, Carolina

AU - van Tinteren, H

AU - de Vries, E. G. E.

AU - Sonke, G. S.

AU - Gietema, Jourik A.

PY - 2018

Y1 - 2018

M3 - Abstract

Y2 - 19 October 2018 through 23 October 2018

ER -

Steenbruggen TG, Steggink L, Seynaeve CM, van der Hoeven JJM, Hooning MJ, Jager A et al.. High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study, Proffered paper (oral presentation) 187O. 2018. Abstract van European Society for Medical Oncology 2018 meeting.